MAPS PBC, rethinking the pharma business model and MDMA-assisted therapy

51:44
 
Share
 

Manage episode 307935462 series 2738732
By Greg Kubin & Matias Serebrinsky, Greg Kubin, and Matias Serebrinsky. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

Today’s episode features Amy Emerson, the CEO of MAPS Public Benefit Corporation (PBC), which is a fully owned subsidiary of MAPS, and its purpose is to commercialize MDMA-assisted therapy. We discuss the MAPS PBC and it’s business model for MDMA-assisted therapy.

In this episode, we discuss:

  • MAPS’ protocol and strategy behind FDA clinical trial for PTSD
  • Amy’s views on the state of the industry, patents, and how to prioritize accessibility
  • The unique business model between MAPS and MAPS PBC
  • Psychedelics for kids

Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin and Matias Serebrinsky
Produced by Jonathan Davis & Zack Frank
Marketing by DaisyMae VanValkenburgh

Find us at businesstrip.fm
Follow us on Instagram and Twitter!

Theme music by Dorian Love
Additional music: Focus Does the Girl by Muted Circus

20 episodes